Marco Gerling

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

End Stage Renal Disease

Prostate Cancer

Machine Learning

Top Venues

Journal for immunotherapy of cancer

Nature communications

Karolinska Universitetssjukhuset

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Karolinska Universitetssjukhuset Aug 21 2017

Sweden

physician :: Tema Cancer, oncology

Publications

Lisa L Liu, Marcus Skribek, Ulrika Harmenberg, Marco Gerling
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature. Journal for immunotherapy of cancer 11 (3) (2023)
Lisa L Liu, Marcus Skribek, Ulrika Harmenberg, Marco Gerling
Systemic inflammatory syndromes as life-threatening side effects of immune checkpoint inhibitors: case report and systematic review of the literature. Journal for immunotherapy of cancer 11 (3) (2023)
Carlos Fernandez Moro, Natalie Geyer, Sara Harrizi, Yousra Hamidi, Sara Söderqvist, Danyil Kuznyecov, Evelina Tidholm Qvist, Media Salmonson Schaad, Laura Hermann, Amanda Lindberg, Rainer L Heuchel, Alfonso Martín-Bernabé, Soniya Dhanjal, Anna C Navis, Christina Villard, Andrea C Del Valle, Lorand Bozóky, Ernesto Sparrelid, Luc Dirix, Carina Strell, Arne Östman, Bernhard Schmierer, Peter B Vermeulen, Jennie Engstrand, Béla Bozóky, Marco Gerling
An idiosyncratic zonated stroma encapsulates desmoplastic liver metastases and originates from injured liver. Nature communications 14 (1) (2023)
Maximilian Kordes, Marco Gerling
Variations in the management of diarrhoea induced by cancer therapy: results from an international, cross-sectional survey among European oncologists. ESMO open 4 (6) (2019)